The utility of cyclodextrins for enhancing oral bioavailability.
about
Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasisOral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulationsModified β-cyclodextrin inclusion complex to improve the physicochemical properties of albendazole. complete in vitro evaluation and characterizationCharacterization of albendazole-randomly methylated-β-cyclodextrin inclusion complex and in vivo evaluation of its antihelmitic activity in a murine model of TrichinellosisExcimer emission in norepinephrine and epinephrine drugs with α- and β-cyclodextrins: spectral and molecular modeling studies.Innovative oral spray-dried Idebenone systems to improve patient compliance.Preformulation study of the inclusion complex irbesartan-beta-cyclodextrinEtodolac/cyclodextrin formulations: physicochemical characterization and in vivo pharmacological studies.Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.Experimental, molecular docking investigations and bioavailability study on the inclusion complexes of finasteride and cyclodextrins.Enhancement of naringenin bioavailability by complexation with hydroxypropyl-β-cyclodextrin. [corrected]Pharmacokinetics and pharmacodynamics of nasally delivered midazolamPreparation and characterization of inclusion complexes of a hemisuccinate ester prodrug of delta9-tetrahydrocannabinol with modified beta-cyclodextrins.Preparation, Physicochemical Characterization and I n - vitro Dissolution Studies of Diosmin-cyclodextrin Inclusion Complexes.Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins.Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.Effect of γ-Cyclodextrin Inclusion Complex on the Absorption of R-α-Lipoic Acid in RatsImproved oral bioavailability of poorly water-soluble glimepiride by utilizing microemulsion techniqueInvestigation of Inclusion Complex of Patchouli Alcohol with β-CyclodextrinThe formation of a host-guest inclusion complex system between β-cyclodextrin and baicalin and its dissolution characteristics.Molecular modeling-based inclusion mechanism and stability studies of doxycycline and hydroxypropyl-β-cyclodextrin complex for ophthalmic delivery.Bioavailability of an R-α-Lipoic Acid/γ-Cyclodextrin Complex in Healthy Volunteers.The Drug Excipient Cyclodextrin Interacts With d-Luciferin and Interferes With Bioluminescence ImagingCyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspectiveAdvances in the pulmonary delivery of poorly water-soluble drugs: influence of solubilization on pharmacokinetic properties.Technology for improving the bioavailability of small molecules extracted from traditional Chinese medicines.Cyclodextrins for drug delivery.Promising complexes of acetazolamide for topical ocular administration.Cyclodextrin-based gene delivery systems.Cyclodextrin-poly(anhydride) nanoparticles as new vehicles for oral drug delivery.Oral formulation strategies to improve solubility of poorly water-soluble drugs.Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.Generic maintenance immunosuppression in solid organ transplant recipients.The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs.Molecular buckets: cyclodextrins for oral cancer therapy.Functional supramolecular polymers for biomedical applications.Model predicting impact of complexation with cyclodextrins on oral absorption.Supramolecular cyclodextrin-based drug nanocarriers.Solid dispersion formulations of megestrol acetate with copovidone for enhanced dissolution and oral bioavailability.Cyclodextrin complexes for treatment improvement in infectious diseases.
P2860
Q27306003-26484FE3-1911-4C61-9559-4089FBD25F4EQ28534686-F6AA4994-5163-4135-B8F0-1E1768648D3CQ28539812-7795AAA1-784C-44FA-93BC-7107FE099010Q28545036-5E8270D7-B264-4FC9-A885-36524658C6BCQ30827585-D065A2A7-2C89-4DB0-86C5-7092777F8520Q31021104-BFE5FDAA-1FAD-4D50-A1EE-442086965EB8Q33417733-FCE8EB17-2789-44A1-89E8-A19748262FB6Q33452151-4312F337-5251-4C4A-9EA9-7BD9419BEB26Q33506237-160B0765-7169-40CD-9B31-E65670D07ECBQ33803717-9575B8FA-8DE8-4F5D-AF89-BFD2AD1A6E09Q33873730-298B9704-C7EE-4B4D-BAD7-C66402511184Q33906315-2A22A8F5-8C6C-49E5-AB07-DB1077987655Q33986035-F9A5B90A-12B5-494F-B53B-D9DF0A9345FBQ34515873-CA659130-2030-4A0D-AD20-F908DD371D0CQ35100405-4FD03EBA-23F3-403F-92FA-AC823ADCC1CEQ35577222-F94994D6-3251-468D-AEEA-E7F3A9FC927DQ35723186-4241B52E-B300-49B1-85D8-77B00C1A5B63Q36107736-78AFDD5B-D4AD-4881-A7E7-93CD925483C7Q36251199-1FE0F8C0-D678-437F-93EC-98540578786AQ36310011-F04E1E04-EA45-4AE5-84FA-7CC514936A57Q36636481-56FFBBF2-C697-4EF9-8B30-64ECD921EB7EQ37050812-A0A129E1-9E66-4E72-A996-02213725B099Q37170669-DF21FD47-C588-4E23-9A8B-6F99141D20F3Q37454370-61A480C3-2482-49FD-89FE-F4D8C7A82B95Q37565681-D3B31BD6-0825-432B-9554-45E661230536Q37620367-DD2F147B-7C9E-488B-8BA6-18334946C38CQ37760218-F89539C1-3C34-443B-BE53-B2E52125839EQ37766607-8D9EC6AC-199B-41BD-A576-7E20370CFF72Q37806096-A004ADBD-B0D0-455B-A164-185468230C36Q37861223-5072FC98-FC44-4912-B06C-C39CBC475470Q37910262-13FDF090-F123-4FF8-A28C-4400FB039074Q37932560-F515B9D6-0C18-4262-B849-543CB52D1FEFQ37949392-E7529754-9088-4548-A738-9EADFA441783Q37990748-2FF59BD5-DBC6-40D1-AE67-1B0DBE2C6905Q38029632-495E468A-E485-42D5-8AB5-8474B1E65D1AQ38267889-1DC188A1-9391-4BF9-A1F8-C6C33B9529FEQ38316288-F9C97D48-3733-4B1E-9A42-40CC13804C71Q38354545-EA2169A7-BE38-46E1-AB86-3FEC4E525AFFQ38475312-00E41FAB-C81B-42D6-B660-BA0AD0999EBDQ38501664-5838A85D-5A40-478E-B88F-C62D572B3630
P2860
The utility of cyclodextrins for enhancing oral bioavailability.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The utility of cyclodextrins for enhancing oral bioavailability.
@en
type
label
The utility of cyclodextrins for enhancing oral bioavailability.
@en
prefLabel
The utility of cyclodextrins for enhancing oral bioavailability.
@en
P2093
P1476
The utility of cyclodextrins for enhancing oral bioavailability.
@en
P2093
Imran Ahmed
Lee A Miller
Rebecca L Carrier
P356
10.1016/J.JCONREL.2007.07.018
P407
P577
2007-08-16T00:00:00Z